Abstracts

HIV/HCV VS HCV: PLASMA AND LIVER VIRAL DYNAMICS AND IP-10 LEVELS

HIV/HCV co-infected people have worse liver disease progression than HCV mono-infected people. Interferon-free therapies have yielded high rates of sustained virologic response after 12 weeks, but shorter therapy has not been uniformly successful in HIV/HCV co-infection. We compared how quickly the liver is cleared of infection with interferon-free therapy in HIV/HCV co-infection and HCV mono-infection.…

CD4+ T-CELL DEPLETION IN AFRICAN GREEN MONKEYS DOES NOT ALTER DISEASE PROGRESSION

Massive and persistent CD4+ T cell depletion is a hallmark of HIV infection, being associated with impairment of cellular immunity and opportunistic infections. The contribution of CD4+ T cell depletion to SIV/HIV-associated gut dysfunction is unknown. African Green Monkeys (AGMs), a species that do not progress to AIDS, partially recover mucosal CD4+ T cells during chronic infection and…

INFERIORITY OF SHORT DURATION SOFOSBUVIR-VELPATASVIR FOR RECENT HCV (REACT STUDY)

Shortened duration therapy for acute and recently acquired HCV infection has been shown to be highly effective in several small non-randomised studies with direct-acting antiviral agents (DAAs), however guidelines remain conservative in their recommendations with no currently approved regimens for this indication. The REACT study was an NIH-funded multicentre international, open-label, randomised, phase 4 non-inferiority…

HUMAN NK CELLS DEVELOP ANTIGEN-SPECIFIC IMMUNOLOGICAL MEMORY OF HIV

Beyond their ability to eliminate infected cells without the need for prior sensitization, murine, non-human primate and human natural killer (NK) cells have been shown to mediate virus-specific recall responses. However, whether NK cells can mediate HIV antigen-specific immunological memory in humans remains to be demonstrated.  Using calcein acetoxymethyl ester- or flow cytometry-based cytotoxicity assays,…